Anti-hemolytic and peroxyl radical scavenging activity of organoselenium compounds: an in vitro study.
Selenium-containing amino acids, selenocystine (CysSeSeCys), methylselenocysteine (MeSeCys), and selenomethionine (SeMet) have been examined for anti-hemolytic and peroxyl radical scavenging ability. Effect of these compounds on membrane lipid peroxidation, release of hemoglobin, and loss of intracellular K(+) ion as a consequence of peroxyl radicals-induced oxidation of human red blood cells were used to evaluate their anti-hemolytic ability. The peroxyl radicals were generated from thermal degradation of 2,2'-azobis(2-methylpropionamidine) dihydrochloride. Significant delay (t(eff)) was observed in oxidative damage in the presence of the selenium compounds. From the IC(50) values for the inhibition of hemolysis, lipid peroxidation, and K(+) ion leakage, the relative anti-hemolytic ability of the compounds were found to be in the order of CysSeSeCys > MeSeCys > SeMet. The anti-hemolytic abilities of the compounds, when compared with sodium selenite (Na(2)SeO(3)) under identical experimental conditions, were found to be better than Na(2)SeO(3). Relative rate constants estimated for the reaction of MeSeCys and SeMet with peroxyl radicals by competition kinetics using ABTS(2-) as a reference confirmed that all the compounds are efficient peroxyl radical scavengers. Comparison of the GPx-like activity of these compounds, by NADPH-GSH reductase coupled assay, indicated that CysSeSeCys exhibits the highest activity. Based on these results, it is concluded that among the compounds examined, CysSeSeCys, possessing the ability to reduce peroxyl radicals and hydroperoxides showed efficient anti-hemolytic activity.
Kumar
B Santhosh
BS
Department of Physiology, Deccan College of Medical Sciences, Hyderabad, India. santhosh910@rediffmail.com
Kunwar
Amit
A
Singh
Beena G
BG
Ahmad
Adeel
A
Priyadarsini
K Indira
KI
D003545:Cysteine / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism; D003553:Cystine / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism; D016166:Free Radical Scavengers / Q000737:chemistry / Q000378:metabolism*; D006461:Hemolysis; D006801:Humans; D015227:Lipid Peroxidation; D016566:Organoselenium Compounds / Q000737:chemistry / Q000378:metabolism*; D010084:Oxidation-Reduction; D010545:Peroxides / Q000737:chemistry / Q000378:metabolism*; D017279:Selenocysteine / Q000031:analogs & derivatives; D012645:Selenomethionine / Q000737:chemistry / Q000378:metabolism
D016166:Free Radical Scavengers; D016566:Organoselenium Compounds; D010545:Peroxides; D017279:Selenocysteine; C009226:selenocystine; C049375:perhydroxyl radical; D003553:Cystine; D012645:Selenomethionine; D003545:Cysteine; C002979:selenomethylselenocysteine